From GlobeNewswire: 2025-04-16 16:05:00

Annexon, Inc. has granted inducement to a new non-executive employee under the terms of the 2022 Employment Inducement Award Plan. The employee received an option to purchase 105,000 shares of Annexon common stock at an exercise price of $1.54 per share, vesting over 4 years. Annexon Biosciences is developing therapeutics to stop classical complement-driven neurodegeneration for people with neuroinflammatory diseases. Their pipeline includes drug candidates for autoimmune, neurodegenerative, and ophthalmic diseases, aiming to address the unmet needs of over 8 million people worldwide. For more information, visit annexonbio.com.



Read more at GlobeNewswire: Annexon Reports Inducement Grant to New Employee Under